Journal List > Korean J Leg Med > v.37(3) > 1004703

Ahn, Shim, Lee, Lee, Lee, and Roh: Preliminary Study of Effect of Leuprolide Acetate Treatment on Sexual Fantasy of Sex Offenders

Abstract

This study investigated the effect of leuprolide acetate treatment on sex offenders’ sexual fantasies and behaviors, as well as on their criminogenic psychological character and the risk of second conviction. The study participants consisted of 22 sex offenders who were confined to the National Institute of Forensic Psychiatry. Among them, 9 patients were given off-label leuprolide acetate for three months to inhibit sexual impulses, whereas the others were not given any medication. All sex offenders underwent two psychological evaluations; the first evaluation was conducted before starting medication, and the second was conducted after medication. Wilson’ s Sex Fantasy Questionnaire (WSFQ), the Rape Myth Acceptance Scale (RMAS), and the Endorsement of Violence Scale (EVS) were used for evaluation. Leuprolide acetate-treated sex offenders showed a statistically significant decline in the total WSFQ score (p < 0.05). However, the RMAS and EVS scores did not differ after leuprolide acetate treatment, indicating that cognitive distortions like rape myth acceptance and endorsement of violence were unchanged after leuprolide medication. Leuprolide acetate may reduce deviant sexual impulses and fantasies, as suggested by previous research form Korea and other countries. However, it probably cannot alter cognitive distortion. On the basis of these findings, we recommend a combination of leuprolide medication and other therapies, like cognitive behavioral therapy, for the treatment of paraphilic sex offenders.

REFERENCES

1. Supreme Prosecutors’ office 2012 Crime analysis statistics, Seoul (2009-2012). Available at. http://www.spo.go.kr/spo/info/stats.
2. Kim JH, Choi SS, Rhee MS, et al. Effect of sex offenders treatment program on cognitive and emotional characteristics of mentally ill sex offenders. J Forensic Sci. 2012; 57:1608–13.
crossref
3. Marshall WL, Serran GA. Current issues in the assessment and treatment of sexual offenders. Clin Psychol Psychother. 2000; 7:85–96.
crossref
4. Thornton D. Constructing and testing a framework for dynamic risk assessment. Sex Abuse. 2002; 14:139–53.
crossref
5. O Ciardha C, Ward T. Theories of cognitive distortions in sexual offending: what the current research tells us. Trauma Violence Abuse. 2013; 14:5–21.
6. Abel GG, Blanchard EB. The role of fantasy in the treatment of sexual deviation. Arch Gen Psychiatry. 1974; 34:467–75.
crossref
7. Barbaree HE, Marshall WL. The role of male sexual arousal in rape: six models. J Consult Clin Psychol. 1991; 59:621–30.
crossref
8. Proulx J, Perreault C, Ouimet M. Pathways in the offending process of extrafamilial sexual child molesters. Sex Abuse. 1999; 11:117–29.
crossref
9. Protection Legislation Division. Work manual of pharmacotherapy of sex offenders. Seoul: Ministry of Justice, Republic of Korea Publisher;2011. p. 65–70.
10. Hanson RK, Morton-Bourgon KE. The characteristics of persistent sexual offenders: a metaanalysis of recidivism studies. J Consult Clin Psychol. 2005; 73:1154–63.
crossref
11. Baumgartner JV, Scalora MJ, Huss MT. Assessment of the Wilson sex fantasy questionnaire among child molesters and nonsexual forensic offenders. Sex Abuse. 2002; 14:19–30.
crossref
12. Wilson G. Interpretation guidelines to Wilson’ s sex fantasy questionnaire (SFQ). London: Cymeon Pty Ltd. Publisher;2010. p. 1–10.
13. Burt MR. Cultural myths and supports for rape. J Pers Soc Psychol. 1980; 38:217–30.
crossref
14. Lee SJ. Development of rape myths scale. Korean J Soc Pers Psychol. 1999; 13:131–48.
15. Eun HJ, Lee SM, Kim TH. The epidemiological study of posttraumatic stress disorder in an urban area. J Korean Neuropsychiatr Assoc. 2001; 40:581–91.
16. Shin KB, Lee Y, Kim KR, et al. Psychiatric and psychological characteristics of sexual offenders in Korea. J Korean Neuropsychiatr Assoc. 2012; 51:170–7.
crossref
17. Kim HS, Lim MH, Do JA, et al. MMPI characteristics of the sexual offender. Anxiety and Mood. 2012; 8:16–21.
18. McElroy SL, Soutullo CA, Taylor P Jr, et al. Psychiatric features of 36 men convicted of sexual offenses. J Clin Psychiatry. 1999; 60:414–20.
crossref
19. Parks GA, Bard DE. Risk factors for adolescent sex offender recidivism: evaluation of predictive factors and comparison of three groups based upon victim type. Sex Abuse. 2006; 18:319–42.
crossref
20. Cohen LJ, Gans SW, McGeoch PG, et al. Impulsive personality traits in male pedophiles versus healthy controls: is pedophilia an impulsive-aggressive disorder? Compr Psychiatry. 2002; 43:127–34.
crossref
21. Studer LH, Aylwin AS, Reddon JR. Testosterone, sexual offense recidivism, and treatment effect among adult male sex offenders. Sex Abuse. 2005; 17:171–81.
crossref
22. Chiroro P, Bohner G, Viki GT, et al. Rape myth acceptance and rape proclivity: expected dominance versus expected arousal as mediators in acquaintance-rape situations. J Interpers Violence. 2004; 19:427–44.
23. Plaud JJ, Bigwood SJ. The relationship of male self-report of rape supportive attitudes, sexual fantasy, social desirability and physiological arousal to sexually coercive stimuli. J Clin Psychol. 1997; 53:935–42.
crossref
24. Schober JM, Kuhn PJ, Kovacs PG, et al. Leuprolide acetate suppresses pedophilic urges and arousability. Arch Sex Behav. 2005; 34:691–705.
crossref

Table 1.
Demographic Characteristics
Variables Leuprolide injected group (n=9, %) Control group (n=13, %) Total
Age   44.5 ± 15.0 35.4 ± 8.3 39.1 ± 13.2
Marriage state        
  Married 4 (44.4) 5 (38.5) 9 (40.9)
  Unmarried 4 (44.4) 5 (38.5) 9 (40.9)
  Divorced 1 (11.2) 3 (23.0) 4 (18.2)
Education level        
  Elementary school or less 3 (33.3) 5 (38.5) 8 (36.4)
  Middle school 0 (0) 2 (15.5) 2 (9.1)
  High school 6 (66.7) 3 (23.0) 9 (40.9)
  College 0 (0) 3 (23.0) 3 (13.6)
Crime history        
  First time 3 (33.3) 5 (38.5) 8 (36.4)
  Second times 0 (0) 3 (23.0) 3 (13.6)
  Third or more times 6 (66.7) 5 (38.5) 11 (50.0)
Diagnosis        
  Paedophilia 3 (33.2) 6 (46.5) 9 (40.9)
  Voyeurism 1 (11.2) 1 (7.5) 2 (9.1)
  Fetishism 1 (11.2) 1 (7.5) 2 (9.1)
  Exhibitionism 0 (0.0) 2 (15.5) 2 (9.1)
Other disorders of sexual preference 4 (44.4) 3 (23.0) 7 (31.8)
Table 2.
Changes in WSFQ Score of Leuprolide Injected Group and Control Group
  WSFQ score Pre-treatment Post-treatment t-score p-value
Mean SD Mean SD
Leuprolide injected group Exploratory 16.78 11.33 4.11 4.62 3.395 0.009
Intimate 24.89 16.17 11.11 8.04 3.39 0.01
Impersonal 18.56 12.87 5.89 4.76 3.113 0.014
Sadomasochistic 6.44 7.52 2.00 3.04 1.481 0.177
  Total 66.67 45.65 23.11 18.21 3.145 0.014
Control group Exploratory 4.31 4.59 4.23 18.68 0.045 0.965
Intimate 7.00 7.12 8.46 4.78 -0.693 0.501
Impersonal 4.23 4.51 5.00 7.34 -0.553 0.591
Sadomasochistic 2.62 3.95 2.77 4.30 -0.119 0.907
  Total 18.15 16.91 20.46 18.68 -0.39 0.703

WSFQ: Wilson’ s sex fantasy questionnaire

Table 3.
Rape Myth Acceptance Scale (RMAS) Score and Endorsement of Violence Scale (EVS) Score
    Pre-treatment Post-treatment t-score p-value
Mean SD Mean SD
RMAS score Leuprolide injected group 51.22 24.29 52.67 27.61 -0.28 0.786
Control group 64.23 35.10 60.38 31.32 0.693 0.501
EVS1 score Leuprolide injected group 84.11 14.48 86.67 13.40 -1.468 0.18
Control group 74.46 10.57 75.69 12.73 -0.786 0.447

RMAS: Rape myth acceptance scale;

EVS: Endorsement of violence scale

TOOLS
Similar articles